Activating KIRs and NKG2C in viral infections: Toward NK cell memory?

Frontiers in Immunology

Volumn 6, Issue NOV, 2015, Pages

  Della Chiesa, Mariella ^a   Sivori, Simona ^a   Carlomagno, Simona ^a   Moretta, Lorenzo ^b   Moretta, Alessandro ^a  

^a UNIVERSITY OF GENOA   (Italy)

^b BAMBINO GESÙ CHILDREN S HOSPITAL   (Italy)

Author keywords

Activating KIRs; HCMV; HIV; Human NK cells; Memory; NKG2C

Indexed keywords

CD94 ANTIGEN; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR;

ADAPTIVE IMMUNITY; ARTICLE; CELL EXPANSION; CELLULAR IMMUNITY; CHIKUNGUNYA; CYTOMEGALOVIRUS INFECTION; DISEASE COURSE; GENE; HANTAVIRUS INFECTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; HUMAN CYTOMEGALOVIRUS; IMMUNOLOGICAL MEMORY; NATURAL KILLER CELL; NONHUMAN; VIRUS CELL INTERACTION; VIRUS INFECTION;

EID: 84949552824     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2015.00573     Document Type: Article

References (95)

1. Ljunggren HG, Karre K. In search of the 'missing self': MHC molecules and NK cell recognition. Immunol Today (1990) 11(7):237-44. doi: 10.1016/0167-5699(90)90097-S.
2. Moretta A, Marcenaro E, Sivori S, Della Chiesa M, Vitale M, Moretta L. Early liaisons between cells of the innate immune system in inflamed peripheral tissues. Trends Immunol (2005) 26(12):668-75. doi:10.1016/j.it.2005.09.008.
3. Vivier E, Raulet DH, Moretta A, Caligiuri MA, Zitvogel L, Lanier LL, et al. Innate or adaptive immunity? The example of natural killer cells. Science (2011) 331(6013):44-9. doi:10.1126/science.1198687.
4. Long EO, Kim HS, Liu D, Peterson ME, Rajagopalan S. Controlling natural killer cell responses: integration of signals for activation and inhibition. Annu Rev Immunol (2013) 31:227-58. doi:10.1146/annurev-immunol-020711-075005.
5. Braud VM, Allan DSJ, O'Callaghan CA, Soderstrom K, D'Andrea A, Ogg GS, et al. HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C. Nature (1998) 391(6669):795-9. doi:10.1038/35869.
6. Korner C, Altfeld M. Role of KIR3DS1 in human diseases. Front Immunol (2012) 3:326. doi:10.3389/fimmu.2012.00326.
7. Moretta A, Bottino C, Vitale M, Pende D, Biassoni R, Mingari MC, et al. Receptors for HLA class-I molecules in human natural killer cells. Annu Rev Immunol (1996) 14:619-48. doi:10.1146/annurev.immunol.14.1.619.
8. Kim S, Poursine-Laurent J, Truscott SM, Lybarger L, Song YJ, Yang L, et al. Licensing of natural killer cells by host major histocompatibility complex class I molecules. Nature (2005) 436(7051):709-13. doi:10.1038/nature03847.
9. Anfossi N, Andre P, Guia S, Falk CS, Roetynck S, Stewart CA, et al. Human NK cell education by inhibitory receptors for MHC class I. Immunity (2006) 25(2):331-42. doi:10.1016/j.immuni.2006.06.013.
10. Raulet DH, Vance RE. Self-tolerance of natural killer cells. Nat Rev Immunol (2006) 6(7):520-31. doi:10.1038/nri1863.
11. Elliott JM, Yokoyama WM. Unifying concepts of MHC-dependent natural killer cell education. Trends Immunol (2011) 32(8):364-72. doi:10.1016/j.it.2011.06.001.
12. Moretta A, Sivori S, Vitale M, Pende D, Morelli L, Augugliaro R, et al. Existence of both inhibitory (p58) and activatory (p50) receptors for HLA-C molecules in human natural killer cells. J Exp Med (1995) 182(3):875-84. doi:10.1084/jem.182.3.875.
13. Chewning JH, Gudme CN, Hsu KC, Selvakumar A, Dupont B. KIR2DS1-positive NK cells mediate alloresponse against the C2 HLA-KIR ligand group in vitro. J Immunol (2007) 179(2):854-68. doi:10.4049/jimmunol.179.2.854.
14. Stewart CA, Laugier-Anfossi F, Vely F, Saulquin X, Riedmuller J, Tisserant A, et al. Recognition of peptide-MHC class I complexes by activating killer immunoglobulin-like receptors. Proc Natl Acad Sci U S A (2005) 102(37):13224-9. doi:10.1073/pnas.0503594102.
15. Graef T, Moesta AK, Norman PJ, Abi-Rached L, Vago L, Older Aguilar AM, et al. KIR2DS4 is a product of gene conversion with KIR3DL2 that introduced specificity for HLA-A*11 while diminishing avidity for HLA-C. J Exp Med (2009) 206(11):2557-72. doi:10.1084/jem.20091010.
16. Marcenaro E, Carlomagno S, Pesce S, Della Chiesa M, Moretta A, Sivori S. Role of alloreactive KIR2DS1(+) NK cells in haploidentical hematopoietic stem cell transplantation. J Leukoc Biol (2011) 90(4):661-7. doi:10.1189/jlb.0311137.
17. Fauriat C, Ivarsson MA, Ljunggren HG, Malmberg KJ, Michaelsson J. Education of human natural killer cells by activating killer cell immunoglobulin-like receptors. Blood (2010) 115(6):1166-74. doi:10.1182/blood-2009-09-245746.
18. Ivarsson MA, Michaelsson J, Fauriat C. Activating killer cell Ig-like receptors in health and disease. Front Immunol (2014) 5:184. doi:10.3389/fimmu.2014.00184.
19. Liu J, Xiao Z, Ko HL, Shen M, Ren EC. Activating killer cell immunoglobulin-like receptor 2DS2 binds to HLA-A*11. Proc Natl Acad Sci U S A (2014) 111(7):2662-7. doi:10.1073/pnas.1322052111.
20. David G, Djaoud Z, Willem C, Legrand N, Rettman P, Gagne K, et al. Large spectrum of HLA-C recognition by killer Ig-like receptor (KIR)2DL2 and KIR2DL3 and restricted C1 SPECIFICITY of KIR2DS2: dominant impact of KIR2DL2/KIR2DS2 on KIR2D NK cell repertoire formation. J Immunol (2013) 191(9):4778-88. doi:10.4049/jimmunol.1301580.
21. Katz G, Gazit R, Arnon TI, Gonen-Gross T, Tarcic G, Markel G, et al. MHC class I-independent recognition of NK-activating receptor KIR2DS4. J Immunol (2004) 173(3):1819-25. doi:10.4049/jimmunol.173.3.1819.
22. David G, Morvan M, Gagne K, Kerdudou N, Willem C, Devys A, et al. Discrimination between the main activating and inhibitory killer cell immunoglobulin-like receptor positive natural killer cell subsets using newly characterized monoclonal antibodies. Immunology (2009) 128(2):172-84. doi:10.1111/j.1365-2567.2009.03085.x.
23. Czaja K, Borer AS, Schmied L, Terszowski G, Stern M, Gonzalez A. A comprehensive analysis of the binding of anti-KIR antibodies to activating KIRs. Genes Immun (2014) 15(1):33-7. doi:10.1038/gene.2013.58.
24. Della Chiesa M, Romeo E, Falco M, Balsamo M, Augugliaro R, Moretta L, et al. Evidence that the KIR2DS5 gene codes for a surface receptor triggering natural killer cell function. Eur J Immunol (2008) 38(8):2284-9. doi:10.1002/eji.200838434.
25. Hsu KC, Chida S, Geraghty DE, Dupont B. The killer cell immunoglobulin-like receptor (KIR) genomic region: gene-order, haplotypes and allelic polymorphism. Immunol Rev (2002) 190:40-52. doi:10.1034/j.1600-065X.2002.19004.x.
26. Vilches C, Parham P. KIR: diverse, rapidly evolving receptors of innate and adaptive immunity. Annu Rev Immunol (2002) 20:217-51. doi:10.1146/annurev.immunol.20.092501.134942.
27. Falco M, Moretta L, Moretta A, Bottino C. KIR and KIR ligand polymorphism: a new area for clinical applications? Tissue Antigens (2013) 82(6):363-73. doi:10.1111/tan.12262.
28. Uhrberg M, Valiante NM, Shum BP, Shilling HG, Lienert-Weidenbach K, Corliss B, et al. Human diversity in killer cell inhibitory receptor genes. Immunity (1997) 7(6):753-63. doi:10.1016/S1074-7613(00)80394-5.
29. Yawata M, Yawata N, Draghi M, Partheniou F, Little AM, Parham P. MHC class I-specific inhibitory receptors and their ligands structure diverse human NK-cell repertoires toward a balance of missing self-response. Blood (2008) 112(6):2369-80. doi:10.1182/blood-2008-03-143727.
30. Schonberg K, Sribar M, Enczmann J, Fischer JC, Uhrberg M. Analyses of HLA-C-specific KIR repertoires in donors with group A and B haplotypes suggest a ligand-instructed model of NK cell receptor acquisition. Blood (2011) 117(1):98-107. doi:10.1182/blood-2010-03-273656.
31. Dunphy SE, Guinan KJ, Chorcora CN, Jayaraman J, Traherne JA, Trowsdale J, et al. 2DL1, 2DL2 and 2DL3 all contribute to KIR phenotype variability on human NK cells. Genes Immun (2015) 16(5):301-10. doi:10.1038/gene.2015.15.
32. Andersson S, Fauriat C, Malmberg JA, Ljunggren HG, Malmberg KJ. KIR acquisition probabilities are independent of self-HLA class I ligands and increase with cellular KIR expression. Blood (2009) 114(1):95-104. doi:10.1182/blood-2008-10-184549.
33. Jamil KM, Khakoo SI. KIR/HLA interactions and pathogen immunity. J Biomed Biotechnol (2011) 2011:298348. doi:10.1155/2011/298348.
34. Carrington M, Alter G. Innate immune control of HIV. Cold Spring Harb Perspect Med (2012) 2(7):a007070. doi:10.1101/cshperspect.a007070.
35. Zambello R, Teramo A, Barila G, Gattazzo C, Semenzato G. Activating KIRs in chronic lymphoproliferative disorder of NK cells: protection from viruses and disease induction? Front Immunol (2014) 5:72. doi:10.3389/fimmu.2014.00072.
36. Gabriel IH, Sergeant R, Szydlo R, Apperley JF, DeLavallade H, Alsuliman A, et al. Interaction between KIR3DS1 and HLA-Bw4 predicts for progression-free survival after autologous stem cell transplantation in patients with multiple myeloma. Blood (2010) 116(12):2033-9. doi:10.1182/blood-2010-03-273706.
37. Martin MP, Gao X, Lee JH, Nelson GW, Detels R, Goedert JJ, et al. Epistatic interaction between KIR3DS1 and HLA-B delays the progression to AIDS. Nat Genet (2002) 31(4):429-34. doi:10.1038/ng934.
38. Qi Y, Martin MP, Gao X, Jacobson L, Goedert JJ, Buchbinder S, et al. KIR/HLA pleiotropism: protection against both HIV and opportunistic infections. PLoS Pathog (2006) 2(8):e79. doi:10.1371/journal.ppat.0020079.
39. Alter G, Rihn S, Walter K, Nolting A, Martin M, Rosenberg ES, et al. HLA class I subtype-dependent expansion of KIR3DS1+ and KIR3DL1+ NK cells during acute human immunodeficiency virus type 1 infection. J Virol (2009) 83(13):6798-805. doi:10.1128/JVI.00256-09.
40. Alter G, Martin MP, Teigen N, Carr WH, Suscovich TJ, Schneidewind A, et al. Differential natural killer cell-mediated inhibition of HIV-1 replication based on distinct KIR/HLA subtypes. J Exp Med (2007) 204(12):3027-36. doi:10.1084/jem.20070695.
41. Pelak K, Need AC, Fellay J, Shianna KV, Feng S, Urban TJ, et al. Copy number variation of KIR genes influences HIV-1 control. PLoS Biol (2011) 9(11):e1001208. doi:10.1371/journal.pbio.1001208.
42. Gaudieri S, DeSantis D, McKinnon E, Moore C, Nolan D, Witt CS, et al. Killer immunoglobulin-like receptors and HLA act both independently and synergistically to modify HIV disease progression. Genes Immun (2005) 6(8):683-90. doi:10.1038/sj.gene.6364256.
43. Soria A, Guerini FR, Bandera A, Bolognesi E, Uglietti A, Fusco C, et al. KIR-HLA genotypes in HIV-infected patients lacking immunological recovery despite effective antiretroviral therapy. PLoS One (2011) 6(11):e27349. doi:10.1371/journal.pone.0027349.
44. Aranda-Romo S, Garcia-Sepulveda CA, Comas-Garcia A, Lovato-Salas F, Salgado-Bustamante M, Gomez-Gomez A, et al. Killer-cell immunoglobulin-like receptors (KIR) in severe A (H1N1) 2009 influenza infections. Immunogenetics (2012) 64(9):653-62. doi:10.1007/s00251-012-0623-3.
45. O'Connor GM, Seich Al Basatena NK, Olavarria V, MacNamara A, Vine A, Ying Q, et al. In contrast to HIV, KIR3DS1 does not influence outcome in HTLV-1 retroviral infection. Hum Immunol (2012) 73(8):783-7. doi:10.1016/j.humimm.2012.05.006.
46. Trydzenskaya H, Juerchott K, Lachmann N, Kotsch K, Kunert K, Weist B, et al. The genetic predisposition of natural killer cell to BK virus-associated nephropathy in renal transplant patients. Kidney Int (2013) 84(2):359-65. doi:10.1038/ki.2013.59.
47. Zhi-ming L, Yu-lian J, Zhao-lei F, Chun-xiao W, Zhen-fang D, Bing-chang Z, et al. Polymorphisms of killer cell immunoglobulin-like receptor gene: possible association with susceptibility to or clearance of hepatitis B virus infection in Chinese Han population. Croat Med J (2007) 48(6):800-6. doi:10.3325/cmj.2007.6.800.
48. Stern M, Elsasser H, Honger G, Steiger J, Schaub S, Hess C. The number of activating KIR genes inversely correlates with the rate of CMV infection/reactivation in kidney transplant recipients. Am J Transplant (2008) 8(6):1312-7. doi:10.1111/j.1600-6143.2008.02242.x.
49. Cook M, Briggs D, Craddock C, Mahendra P, Milligan D, Fegan C, et al. Donor KIR genotype has a major influence on the rate of Cytomegalovirus reactivation following T-cell replete stem cell transplantation. Blood (2006) 107(3):1230-2. doi:10.1182/blood-2005-03-1039.
50. Zaia JA, Sun JY, Gallez-Hawkins GM, Thao L, Oki A, Lacey SF, et al. The effect of single and combined activating killer immunoglobulin-like receptor genotypes on Cytomegalovirus infection and immunity after hematopoietic cell transplantation. Biol Blood Marrow Transplant (2009) 15(3):315-25. doi:10.1016/j.bbmt.2008.11.030.
51. Di Bona D, Scafidi V, Plaia A, Colomba C, Nuzzo D, Occhino C, et al. HLA and killer cell immunoglobulin-like receptors influence the natural course of CMV infection. J Infect Dis (2014) 210(7):1083-9. doi:10.1093/infdis/jiu226.
52. Stern M, Hadaya K, Honger G, Martin PY, Steiger J, Hess C, et al. Telomeric rather than centromeric activating KIR genes protect from Cytomegalovirus infection after kidney transplantation. Am J Transplant (2011) 11(6):1302-7. doi:10.1111/j.1600-6143.2011.03516.x.
53. Gonzalez A, Schmitter K, Hirsch HH, Garzoni C, van Delden C, Boggian K, et al. KIR-associated protection from CMV replication requires pre-existing immunity: a prospective study in solid organ transplant recipients. Genes Immun (2014) 15(7):495-9. doi:10.1038/gene.2014.39.
54. Mancusi A, Ruggeri L, Urbani E, Pierini A, Massei MS, Carotti A, et al. Haploidentical hematopoietic transplantation from KIR ligand-mismatched donors with activating KIRs reduces nonrelapse mortality. Blood (2015) 125(20):3173-82. doi:10.1182/blood-2014-09-599993.
55. Lopez-Vazquez A, Rodrigo L, Martinez-Borra J, Perez R, Rodriguez M, Fdez-Morera JL, et al. Protective effect of the HLA-Bw4I80 epitope and the killer cell immunoglobulin-like receptor 3DS1 gene against the development of hepatocellular carcinoma in patients with hepatitis C virus infection. J Infect Dis (2005) 192(1):162-5. doi:10.1086/430351.
56. Bonagura VR, Du Z, Ashouri E, Luo L, Hatam LJ, DeVoti JA, et al. Activating killer cell immunoglobulin-like receptors 3DS1 and 2DS1 protect against developing the severe form of recurrent respiratory papillomatosis. Hum Immunol (2010) 71(2):212-9. doi:10.1016/j.humimm.2009.10.009.
57. Diaz-Pena R, Vidal-Castineira JR, Alonso-Arias R, Suarez-Alvarez B, Vicario JL, Solana R, et al. Association of the KIR3DS1*013 and KIR3DL1*004 alleles with susceptibility to ankylosing spondylitis. Arthritis Rheum (2010) 62(4):1000-6. doi:10.1002/art.27332.
58. Azuz-Lieberman N, Markel G, Mizrahi S, Gazit R, Hanna J, Achdout H, et al. The involvement of NK cells in ankylosing spondylitis. Int Immunol (2005) 17(7):837-45. doi:10.1093/intimm/dxh270.
59. Ho M. Epidemiology of Cytomegalovirus infections. Rev Infect Dis (1990) 12(Suppl 7):S701-10. doi:10.1093/clinids/12.Supplement_7.S701.
60. Guma M, Angulo A, Vilches C, Gomez-Lozano N, Malats N, Lopez-Botet M. Imprint of Human cytomegalovirus infection on the NK cell receptor repertoire. Blood (2004) 104(12):3664-71. doi:10.1182/blood-2004-05-2058.
61. Muntasell A, Lopez-Montanes M, Vera A, Heredia G, Romo N, Penafiel J, et al. NKG2C zygosity influences CD94/NKG2C receptor function and the NK-cell compartment redistribution in response to Human cytomegalovirus. Eur J Immunol (2013) 43(12):3268-78. doi:10.1002/eji.201343773.
62. Kuijpers TW, Baars PA, Dantin C, van den Burg M, van Lier RA, Roosnek E. Human NK cells can control CMV infection in the absence of T cells. Blood (2008) 112(3):914-5. doi:10.1182/blood-2008-05-157354.
63. Farnault L, Chambost H, Michel G, Thuret I, de Saint Basile G, Fischer A, et al. Persistence of natural killer cells with expansion of a hypofunctional CD56-CD16+KIR+NKG2C+ subset in a patient with atypical janus kinase 3-deficient severe combined immunodeficiency. J Allergy Clin Immunol (2013) 131(4):e1-2. doi:10.1016/j.jaci.2012.08.047.
64. Guma M, Cabrera C, Erkizia I, Bofill M, Clotet B, Ruiz L, et al. Human cytomegalovirus infection is associated with increased proportions of NK cells that express the CD94/NKG2C receptor in aviremic HIV-1-positive patients. J Infect Dis (2006) 194(1):38-41. doi:10.1086/504719.
65. Brunetta E, Fogli M, Varchetta S, Bozzo L, Hudspeth KL, Marcenaro E, et al. Chronic HIV-1 viremia reverses NKG2A/NKG2C ratio on natural killer cells in patients with Human cytomegalovirus co-infection. AIDS (2010) 24(1):27-34. doi:10.1097/QAD.0b013e3283328d1f.
66. Della Chiesa M, Falco M, Podesta M, Locatelli F, Moretta L, Frassoni F, et al. Phenotypic and functional heterogeneity of human NK cells developing after umbilical cord blood transplantation: a role for Human cytomegalovirus? Blood (2012) 119(2):399-410. doi:10.1182/blood-2011-08-372003.
67. Foley B, Cooley S, Verneris MR, Pitt M, Curtsinger J, Luo X, et al. Cytomegalovirus reactivation after allogeneic transplantation promotes a lasting increase in educated NKG2C+ natural killer cells with potent function. Blood (2011) 119(11):2665-74. doi:10.1182/blood-2011-10-386995.
68. Lopez-Verges S, Milush JM, Schwartz BS, Pando MJ, Jarjoura J, York VA, et al. Expansion of a unique CD57+NKG2Chi natural killer cell subset during acute Human cytomegalovirus infection. Proc Natl Acad Sci U S A (2011) 108(36):14725-32. doi:10.1073/pnas.1110900108.
69. Guma M, Budt M, Saez A, Brckalo T, Hengel H, Angulo A, et al. Expansion of CD94/NKG2C+ NK cells in response to Human cytomegalovirus-infected fibroblasts. Blood (2006) 107(9):3624-31. doi:10.1182/blood-2005-09-3682.
70. Rolle A, Pollmann J, Ewen EM, Le VT, Halenius A, Hengel H, et al. IL-12-producing monocytes and HLA-E control HCMV-driven NKG2C+ NK cell expansion. J Clin Invest (2014) 124(12):5305-16. doi:10.1172/JCI77440.
71. Tortorella D, Gewurz BE, Furman MH, Schust DJ, Ploegh HL. Viral subversion of the immune system. Annu Rev Immunol (2000) 18:861-926. doi:10.1146/annurev.immunol.18.1.861.
72. Heatley SL, Pietra G, Lin J, Widjaja JM, Harpur CM, Lester S, et al. Polymorphism in Human cytomegalovirus UL40 impacts on recognition of human leukocyte antigen-E (HLA-E) by natural killer cells. J Biol Chem (2013) 288(12):8679-90. doi:10.1074/jbc. M112.409672.
73. Michaelsson J, Teixeira de Matos C, Achour A, Lanier LL, Karre K, Soderstrom K. A signal peptide derived from hsp60 binds HLA-E and interferes with CD94/NKG2A recognition. J Exp Med (2002) 196(11):1403-14. doi:10.1084/jem.20020797.
74. Lampen MH, Hassan C, Sluijter M, Geluk A, Dijkman K, Tjon JM, et al. Alternative peptide repertoire of HLA-E reveals a binding motif that is strikingly similar to HLA-A2. Mol Immunol (2013) 53(1-2):126-31. doi:10.1016/j.molimm.2012.07.009.
75. Sun JC, Beilke JN, Lanier LL. Adaptive immune features of natural killer cells. Nature (2009) 457(7229):557-61. doi:10.1038/nature07665.
76. Arase H, Mocarski ES, Campbell AE, Hill AB, Lanier LL. Direct recognition of Cytomegalovirus by activating and inhibitory NK cell receptors. Science (2002) 296(5571):1323-6. doi:10.1126/science.1070884.
77. Min-Oo G, Lanier LL. Cytomegalovirus generates long-lived antigen-specific NK cells with diminished bystander activation to heterologous infection. J Exp Med (2014) 211(13):2669-80. doi:10.1084/jem.20141172.
78. Foley B, Cooley S, Verneris MR, Curtsinger J, Luo X, Waller EK, et al. Human cytomegalovirus (CMV)-induced memory-like NKG2C(+) NK cells are transplantable and expand in vivo in response to recipient CMV antigen. J Immunol (2012) 189(10):5082-8. doi:10.4049/jimmunol.1201964.
79. Schlums H, Cichocki F, Tesi B, Theorell J, Beziat V, Holmes TD, et al. Cytomegalovirus infection drives adaptive epigenetic diversification of NK cells with altered signaling and effector function. Immunity (2015) 42(3):443-56. doi:10.1016/j.immuni.2015.02.008.
80. Lee J, Zhang T, Hwang I, Kim A, Nitschke L, Kim M, et al. Epigenetic modification and antibody-dependent expansion of memory-like NK cells in Human cytomegalovirus-infected individuals. Immunity (2015) 42(3):431-42. doi:10.1016/j.immuni.2015.02.013.
81. Wu Z, Sinzger C, Frascaroli G, Reichel J, Bayer C, Wang L, et al. Human cytomegalovirus-induced NKG2C(hi) CD57(hi) natural killer cells are effectors dependent on humoral antiviral immunity. J Virol (2013) 87(13):7717-25. doi:10.1128/JVI.01096-13.
82. Corrales-Aguilar E, Hoffmann K, Hengel H. CMV-encoded Fcgamma receptors: modulators at the interface of innate and adaptive immunity. Semin Immunopathol (2014) 36(6):627-40. doi:10.1007/s00281-014-0448-2.
83. Luetke-Eversloh M, Hammer Q, Durek P, Nordstrom K, Gasparoni G, Pink M, et al. Human cytomegalovirus drives epigenetic imprinting of the IFNG locus in NKG2Chi natural killer cells. PLoS Pathog (2014) 10(10):e1004441. doi:10.1371/journal.ppat.1004441.
84. Sun JC, Lanier LL. NK cell development, homeostasis and function: parallels with CD8(+) T cells. Nat Rev Immunol (2011) 11(10):645-57. doi:10.1038/nri3044.
85. Marcus A, Raulet DH. Evidence for natural killer cell memory. Curr Biol (2013) 23(17):R817-20. doi:10.1016/j.cub.2013.07.015.
86. Williams MA, Bevan MJ. Effector and memory CTL differentiation. Annu Rev Immunol (2007) 25:171-92. doi:10.1146/annurev.immunol.25.022106.141548.
87. Beziat V, Liu LL, Malmberg JA, Ivarsson MA, Sohlberg E, Bjorklund AT, et al. NK cell responses to cytomegalovirus infection lead to stable imprints in the human KIR repertoire and involve activating KIRs. Blood (2013) 121(14):2678-88. doi:10.1182/blood-2012-10-459545.
88. Della Chiesa M, Falco M, Bertaina A, Muccio L, Alicata C, Frassoni F, et al. Human cytomegalovirus infection promotes rapid maturation of NK cells expressing activating killer Ig-like receptor in patients transplanted with NKG2C-/-umbilical cord blood. J Immunol (2014) 192(4):1471-9. doi:10.4049/jimmunol.1302053.
89. Bjorkstrom NK, Lindgren T, Stoltz M, Fauriat C, Braun M, Evander M, et al. Rapid expansion and long-term persistence of elevated NK cell numbers in humans infected with hantavirus. J Exp Med (2011) 208(1):13-21. doi:10.1084/jem.20100762.
90. Petitdemange C, Becquart P, Wauquier N, Beziat V, Debre P, Leroy EM, et al. Unconventional repertoire profile is imprinted during acute chikungunya infection for natural killer cells polarization toward cytotoxicity. PLoS Pathog (2011) 7(9):e1002268. doi:10.1371/journal.ppat.1002268.
91. Beziat V, Dalgard O, Asselah T, Halfon P, Bedossa P, Boudifa A, et al. CMV drives clonal expansion of NKG2C+ NK cells expressing self-specific KIRs in chronic hepatitis patients. Eur J Immunol (2012) 42(2):447-57. doi:10.1002/eji.201141826.
92. Hendricks DW, Balfour HH Jr, Dunmire SK, Schmeling DO, Hogquist KA, Lanier LL. Cutting edge: NKG2C(hi)CD57+ NK cells respond specifically to acute infection with Cytomegalovirus and not Epstein-Barr virus. J Immunol (2014) 192(10):4492-6. doi:10.4049/jimmunol.1303211.
93. Azzi T, Lunemann A, Murer A, Ueda S, Beziat V, Malmberg KJ, et al. Role for early-differentiated natural killer cells in infectious mononucleosis. Blood (2014) 124(16):2533-43. doi:10.1182/blood-2014-01-553024.
94. Romee R, Schneider SE, Leong JW, Chase JM, Keppel CR, Sullivan RP, et al. Cytokine activation induces human memory-like NK cells. Blood (2012) 120(24):4751-60. doi:10.1182/blood-2012-04-419283.
95. Reeves RK, Li H, Jost S, Blass E, Li H, Schafer JL, et al. Antigen-specific NK cell memory in rhesus macaques. Nat Immunol (2015) 16(9):927-32. doi:10.1038/ni.3227.